Sample Page
Author:
Royalty Pharma plc
Posted Date:
May 7, 2026
Royalty Pharma to present at upcoming investor conferences
Royalty Pharma plc
May 7, 2026
Royalty Pharma reports first quarter 2026 results
Royalty Pharma plc
May 6, 2026
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
Royalty Pharma plc
April 21, 2026
Royalty Pharma Declares Second Quarter 2026 Dividend
Royalty Pharma plc
April 17, 2026
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
Royalty Pharma plc
April 15, 2026
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
Royalty Pharma plc
March 30, 2026
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
Royalty Pharma plc
March 23, 2026
Royalty Pharma Announces Expansion of Leadership Team
Royalty Pharma plc
March 17, 2026
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma’s Global Platform
Royalty Pharma plc
March 2, 2026
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
Royalty Pharma plc
March 2, 2026
1
2
Next
